| Patent Number |
Title Of Patent |
Date Issued |
| 6911206 |
Fusion proteins comprising carriers that can induce a dual immune response |
June 28, 2005 |
| The subject invention provides a fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises: (a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is t |
| 6787146 |
Neospora vaccine |
September 7, 2004 |
| The present invention provides an homogenate prepared from cells of Neospora, and vaccines against neosporosis prepared therefrom which are useful in the prevention of clinical disease and abortion in mammals. |
| 6713071 |
Proteins from actinobacillus pleuropneumoniae |
March 30, 2004 |
| The present invention is directed to five novel, low molecular weight proteins from Actinobacillus pleuropneumoniae (APP), which are capable of inducing, or contributing to the induction of, a protective immune response in swine against APP. The present invention is further directed |
| 6270800 |
Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine |
August 7, 2001 |
| A microencapsulated subunit component from bovine herpes virus-1 (BHV-1) is disclosed. Vaccines, kits, and methods for using the same to vaccinate a member of a bovine species are also disclosed. |
| 6096320 |
Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurel |
August 1, 2000 |
| New chimeric proteins, DNA encoding the same, and the use of these proteins in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The chimeric proteins include at least one epitope of an RTX cytotoxin fused to an active |
| 5594107 |
Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon |
January 14, 1997 |
| New chimeric proteins, DNA encoding the same, and the use of these proteins in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The chimeric proteins include at least one epitope of an RTX cytotoxin fused to an active |
| 5503833 |
VP6 encapsulated drug delivery |
April 2, 1996 |
| Compositions and methods for preparing and delivering encapsulated biologically active agents to specific cell types are disclosed. Substances can be encapsulated in the VP6 inner capsid protein of rotavirus and delivered to selected cells, tissues and organs. Targeting agents can be |
| 5431899 |
Rotavirus VP6 as a diagnostic and targeting agent |
July 11, 1995 |
| Advantage is taken of the ability of rotaviral VP6 protein to home to macrophage and monocytes to provide label to these cells in either an in vitro or in vivo environment. Further, the ability to couple label to the VP6 protein and to couple VP6 to a targeting agent provides a mechanism |
| 5273889 |
Gamma-iterferon-leukotoxin gene fusions and uses thereof |
December 28, 1993 |
| New chimeric proteins, DNA encoding the same, and the use of these proteins in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The chimeric proteins include at least one epitope of leukotoxin fused to an active fragm |
| 5238823 |
Interleukin-2-leukotoxin gene fusions and uses thereof |
August 24, 1993 |
| New chimeric proteins, DNA encoding the same, and the use of these proteins in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The chimeric proteins include at least one epitope of leukotoxin fused to an active fragm |
| 5049378 |
Prevention and treatment of porcine haemophilus pneumonia (PHP) |
September 17, 1991 |
| Methods of treating diseases in swine are disclosed using porcine interferon alpha and/or gamma. |
